Finnish study finds poor oral health increases jawbone necrosis risks in breast cancer patients
Antiresorptive drugs, which reduce bone breakdown, are an important part of treatment for breast cancer that has spread to the bones. However, their use can be associated with osteonecrosis of the jaw (MRONJ), a condition in which bone tissue in the jaw dies.
Read original article on The Medical News →Related news
-
Wearable cyborg training linked to longer walking distances in people with ALS
United Kingdom
-
AI misuse and nuclear famine could threaten humanity's survival before 2100
United Kingdom
-
Jawbone necrosis in advanced breast cancer: Study highlights the importance of oral health
United Kingdom
-
The crucial responsibilities doctors must never offshore to AI
United Kingdom
-
Common asthma drug improves strength in children with muscle disease
United Kingdom
-
Inflation sizzled in September — and Social Security benefits will get a boost
United States
-
Chronic inflammation spikes during the earliest phase of cardiovascular-kidney-metabolic syndrome
United Kingdom
-
Depression in OB-GYN residents needs more attention, study suggests
United Kingdom